These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 36162167)

  • 1. Post-contrast MRI in multiple sclerosis: Towards a judicious use of gadolinium-based contrast agents.
    Gentili L; Capuano R; Gaetani L; Fiacca A; Bisecco A; d'Ambrosio A; Mancini A; Guercini G; Tedeschi G; Parnetti L; Gallo A; Di Filippo M
    J Neurol Sci; 2022 Nov; 442():120422. PubMed ID: 36162167
    [No Abstract]   [Full Text] [Related]  

  • 2. 2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis.
    Wattjes MP; Ciccarelli O; Reich DS; Banwell B; de Stefano N; Enzinger C; Fazekas F; Filippi M; Frederiksen J; Gasperini C; Hacohen Y; Kappos L; Li DKB; Mankad K; Montalban X; Newsome SD; Oh J; Palace J; Rocca MA; Sastre-Garriga J; Tintoré M; Traboulsee A; Vrenken H; Yousry T; Barkhof F; Rovira À; ; ;
    Lancet Neurol; 2021 Aug; 20(8):653-670. PubMed ID: 34139157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-brain barrier breakdown in non-enhancing multiple sclerosis lesions detected by 7-Tesla MP2RAGE ΔT1 mapping.
    Choi S; Spini M; Hua J; Harrison DM
    PLoS One; 2021; 16(4):e0249973. PubMed ID: 33901207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadolinium Retention in the Brain: An MRI Relaxometry Study of Linear and Macrocyclic Gadolinium-Based Contrast Agents in Multiple Sclerosis.
    Forslin Y; Martola J; Bergendal Å; Fredrikson S; Wiberg MK; Granberg T
    AJNR Am J Neuroradiol; 2019 Aug; 40(8):1265-1273. PubMed ID: 31248867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine Gadolinium Use for MRI Follow-Up of Multiple Sclerosis: Counterpoint-Gadolinium Should Not Always Be Used to Assess Disease Activity.
    Rovira À; Auger C
    AJR Am J Roentgenol; 2022 Jul; 219(1):26-27. PubMed ID: 34786958
    [No Abstract]   [Full Text] [Related]  

  • 6. Contrast enhanced magnetic resonance imaging of the brain using gadolinium-DTPA.
    Valk J; de Slegte RG; Crezee FC; Hazenberg GJ; Thjaha SI; Nauta JJ
    Acta Radiol; 1987; 28(6):659-65. PubMed ID: 2962597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosis.
    Lie IA; Kerklingh E; Wesnes K; van Nederpelt DR; Brouwer I; Torkildsen Ø; Myhr KM; Barkhof F; Bø L; Vrenken H
    Eur Radiol; 2022 May; 32(5):3576-3587. PubMed ID: 34978580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered signal intensity of active enhancing inflammatory lesions using post-contrast double inversion recovery MR sequence.
    Hodel J; Badr S; Outteryck O; Lebert P; Chechin D; Benadjaoud MA; Pruvo JP; Vermersch P; Leclerc X
    Eur Radiol; 2017 Feb; 27(2):637-641. PubMed ID: 27229340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New OFSEP recommendations for MRI assessment of multiple sclerosis patients: Special consideration for gadolinium deposition and frequent acquisitions.
    Brisset JC; Kremer S; Hannoun S; Bonneville F; Durand-Dubief F; Tourdias T; Barillot C; Guttmann C; Vukusic S; Dousset V; Cotton F;
    J Neuroradiol; 2020 Jun; 47(4):250-258. PubMed ID: 32014494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine Gadolinium Use for MRI Follow-Up of Multiple Sclerosis: Point-The Role of Leptomeningeal Enhancement.
    Okar SV; Reich DS
    AJR Am J Roentgenol; 2022 Jul; 219(1):24-25. PubMed ID: 34786959
    [No Abstract]   [Full Text] [Related]  

  • 11. Gadolinium and Multiple Sclerosis: Vessels, Barriers of the Brain, and Glymphatics.
    Saade C; Bou-Fakhredin R; Yousem DM; Asmar K; Naffaa L; El-Merhi F
    AJNR Am J Neuroradiol; 2018 Dec; 39(12):2168-2176. PubMed ID: 30385472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between gadolinium-enhanced 2D T1-weighted gradient-echo and spin-echo sequences in the detection of active multiple sclerosis lesions on 3.0T MRI.
    Aymerich FX; Auger C; Alcaide-Leon P; Pareto D; Huerga E; Corral JF; Mitjana R; Sastre-Garriga J; Montalban X; Rovira A
    Eur Radiol; 2017 Apr; 27(4):1361-1368. PubMed ID: 27456965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Unenhanced and Gadolinium-Enhanced Imaging in Multiple Sclerosis: Is Contrast Needed for Routine Follow-Up MRI?
    Sadigh G; Saindane AM; Waldman AD; Lava NS; Hu R
    AJNR Am J Neuroradiol; 2019 Sep; 40(9):1476-1480. PubMed ID: 31439627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the Relevance of the Systematic Use of Gadolinium During the MRI Follow-Up of Multiple Sclerosis Patients Under Natalizumab?
    Bellanger G; Biotti D; Patsoura S; Ciron J; Ferrier M; Gramada R; Meluchova Z; Lerebours F; Catalaa I; Dumas H; Cognard C; Brassat D; Bonneville F
    Clin Neuroradiol; 2020 Sep; 30(3):553-558. PubMed ID: 31143968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients.
    Splendiani A; Perri M; Marsecano C; Vellucci V; Michelini G; Barile A; Di Cesare E
    Radiol Med; 2018 Feb; 123(2):125-134. PubMed ID: 28952018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Use of Noncontrast Quantitative MRI to Detect Gadolinium-Enhancing Multiple Sclerosis Brain Lesions: A Systematic Review and Meta-Analysis.
    Gupta A; Al-Dasuqi K; Xia F; Askin G; Zhao Y; Delgado D; Wang Y
    AJNR Am J Neuroradiol; 2017 Jul; 38(7):1317-1322. PubMed ID: 28522663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The pharmacological economic analysis of application of magnetic resonance contrast mediums containing gadolinium in case of multiple sclerosis].
    Shegay MM; Shimanovsky DN
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2021 Mar; 29(2):343-346. PubMed ID: 33901380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of contrast-enhanced and non-contrast-enhanced MRI in the follow-up of multiple sclerosis.
    Zarei F; Ghaedian M; Ghaedian T
    Acta Radiol; 2021 Jul; 62(7):916-921. PubMed ID: 32762243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of Unenhanced MRI in the Detection of New Brain Lesions in Multiple Sclerosis.
    Eichinger P; Schön S; Pongratz V; Wiestler H; Zhang H; Bussas M; Hoshi MM; Kirschke J; Berthele A; Zimmer C; Hemmer B; Mühlau M; Wiestler B
    Radiology; 2019 May; 291(2):429-435. PubMed ID: 30860448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of enhancing lesions in monitoring multiple sclerosis treatment: is gadolinium always necessary?
    Tsantes E; Curti E; Ganazzoli C; Puci F; Bazzurri V; Fiore A; Crisi G; Granella F
    J Neurol; 2020 Sep; 267(9):2642-2647. PubMed ID: 32399696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.